The strengths of this study are the short median time interval between ischemic stroke debut and blood sampling (<8 h), the sampling of blood prior to thrombolysis, the discrimination of ischemic stroke from TIA patients, and the inclusion of IL-6 and S100B. This evidence concerns the gene S100B and ischemic stroke.